Shelton W. Barnes, M.D.; Decision and Order, 5983-5984 [2020-01967]
Download as PDF
Federal Register / Vol. 85, No. 22 / Monday, February 3, 2020 / Notices
barriers to importation in foreign
markets or changes in market demand
abroad). Demand conditions to consider
include end uses and applications; the
existence and availability of substitute
products; and the level of competition
among the Domestic Like Product
produced in the United States, Subject
Merchandise produced in the Subject
Country, and such merchandise from
other countries.
(13) (OPTIONAL) A statement of
whether you agree with the above
definitions of the Domestic Like Product
and Domestic Industry; if you disagree
with either or both of these definitions,
please explain why and provide
alternative definitions.
Authority: This proceeding is being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.61 of the
Commission’s rules.
By order of the Commission.
Issued: January 29, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–01980 Filed 1–31–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
lotter on DSKBCFDHB2PROD with NOTICES
Shelton W. Barnes, M.D.; Decision and
Order
On June 28, 2019, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause to Shelton W. Barnes, M.D.,
(hereinafter, Registrant), of New
Orleans, Louisiana. Order to Show
Cause (hereinafter, OSC), at 1. The OSC
proposed the revocation of Registrant’s
Certificate of Registration No.
BB1040269, because the United States
Department of Health and Human
Services, Office of Inspector General
(hereinafter, HHS OIG) ‘‘mandatorily
excluded [Registrant] from participation
in Medicare, Medicaid, and all Federal
health care programs for a minimum
period of twenty-five years pursuant to
42 U.S.C. 1320a–7(a)’’; and such
exclusion ‘‘warrants revocation of
[Registrant’s] registration pursuant to 21
U.S.C. 824(a)(5).’’ Id. at 2.
Specifically, the OSC alleged that, on
September 25, 2018, Judgment was
entered against Registrant in the United
States District Court for the Eastern
District of Louisiana (hereinafter, E.D.
La.) ‘‘based on [Registrant’s] conviction
on one count of ‘Conspiracy to Commit
VerDate Sep<11>2014
16:47 Jan 31, 2020
Jkt 250001
Health Care Fraud,’ in violation of 18
U.S.C. 1349, one count of ‘Conspiracy to
Pay and Receive Illegal Health Care
Kickbacks,’ in violation of 18 U.S.C.
371, fifteen counts of ‘Health Care
Fraud,’ in violation of 18 U.S.C. 1347
and 2,1 and one count of ‘Obstruction of
a Federal Audit,’ in violation of 18
U.S.C. 1516 and 2.’’ 2 Id. at 2 (citing
United States v. Barnes, No. 2:15–cr–
0061–SM–JCW (E.D. La. 2018)). The
OSC further alleged that ‘‘based on
[such] conviction, HHS OIG, by letter
dated March 29, 2019, mandatorily
excluded [Registrant] from participation
in Medicare, Medicaid, and all Federal
health care programs for a minimum
period of twenty-five years pursuant to
42 U.S.C. 1320a–7(a), effective April 18,
2019.’’ Id.
The Show Cause Order notified
Registrant of the right to request a
hearing on the allegations or to submit
a written statement, while waiving the
right to a hearing, the procedures for
electing each option, and the
consequences for failing to elect either
option. Id. at 2–3 (citing 21 CFR
1301.43). The OSC also notified
Registrant of the opportunity to submit
a corrective action plan. Id. at 3–4
(citing 21 U.S.C. 824(c)(2)(C)).
Adequacy of Service
In a Declaration, dated October 24,
2019, a Diversion Investigator
(hereinafter, DI) assigned to the New
Orleans Field Division stated that she
and another DI traveled to the Federal
Prison Camp Pensacola, 110 Raby Ave.,
Pensacola, Florida 32509, where
Registrant was incarcerated, on July 10,
2019. Request for Final Agency Action
(hereinafter, RFAA), EX 6 (Declaration
of Service). The DI stated that they were
taken to a room where correctional
officers brought in Registrant, who ‘‘was
wearing an inmate nametag with his
name on it,’’ and she further
‘‘recognized him based on his driver’s
license photo.’’ Id. The DI then ‘‘handed
the [OSC] to [Registrant] and explained
it to him, including his options to
request a hearing or surrender his
registration.’’ Id.
The Government submitted its RFAA,
along with the evidentiary record, for
adjudication on December 4, 2019. In its
RFAA, the Government represented that
‘‘at least thirty days have passed since
the . . . [OSC] was served on Registrant.
Registrant has not requested a hearing
and has not otherwise corresponded or
communicated with DEA regarding the
Order served on him, including the
1 The Court’s notation of 18 U.S.C. 2 appears in
this format, which was replicated in the OSC.
2 See n.1.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
5983
filing of any written statement in lieu of
a hearing.’’ RFAA, at 2. The Government
requested that Registrant’s Certificate of
Registration be revoked and his pending
application for renewal be denied
‘‘because Registrant lacks state authority
and because Registrant has been
excluded from Medicare, Medicaid and
all Federal health care programs, either
of which alone is a sufficient basis to
revoke Registrant’s registration
. . . .’’ 3 Id. at 7.
Based on the Government’s
representations and my review of the
record, I find that the Government
served the OSC on Registrant on July 10,
2019. I also find that more than thirty
days have now passed since the date of
service. Further, based on the
Government’s representations, I find
that neither Registrant, nor anyone
purporting to represent the Registrant,
requested a hearing, submitted a written
statement while waiving Registrant’s
right to a hearing, or submitted a
corrective action plan. Accordingly, I
find that Registrant has waived the right
to a hearing and the right to submit a
written statement and corrective action
plan. 21 CFR § 1301.43(d) and 21 U.S.C.
824(c)(2)(C). I, therefore, issue this
Decision and Order based on the record
submitted by the Government, which
constitutes the entire record before me.
21 CFR 1301.43(e).
Findings of Fact
Registrant’s DEA Registration
Registrant is the holder of DEA
Certificate of Registration No.
BB1040269 at the registered address of
3600 Prytania, Suite 50, New Orleans,
LA 70115. RFAA, EX 1 (Certificate of
Registration History), at 1. Pursuant to
this registration, Registrant is authorized
to dispense controlled substances in
schedules II through V as a practitioner.
Id. Registrant’s registration was set to
expire on July 31, 2018, but on that date,
Registrant submitted an online renewal
application for 10555 Lake Forest Blvd.,
Ste. 5J, New Orleans, LA 70127–5208,
3 In the RFAA, the Government argued for
revocation based on a ground that does not appear
in the OSC—that the Registrant currently lacks
authority to practice medicine in Louisiana, the
state in which he is registered with the DEA, and
his registration is thus also subject to revocation
pursuant to 21 U.S.C. 824(a)(3). Although state
authority is a prerequisite to holding (or having) a
DEA registration, see 21 U.S.C. 823, I see no
evidence in the record that Registrant was notified
of this additional charge. As such, he has had no
opportunity to determine whether to address the
status of his state authority. See Hatem M. Ataya,
M.D., 81 FR 8221, 8245 (2016) (permitting the
consideration of 21 U.S.C. 824(a)(3), because the
respondent had a ‘‘meaningful opportunity to show
that he retains his state authority.’’). In this case, I
decline to allow the Government to add the lack of
state authority charge.
E:\FR\FM\03FEN1.SGM
03FEN1
5984
Federal Register / Vol. 85, No. 22 / Monday, February 3, 2020 / Notices
and his registration is currently ‘‘in a
renewal pending status.’’ Id.
lotter on DSKBCFDHB2PROD with NOTICES
Registrant’s Exclusion
The evidence in the record
demonstrates that, on September 25,
2018, Judgment was entered against
Registrant in E.D. La. ‘‘based on
[Registrant’s] conviction on one count of
‘Conspiracy to Commit Health Care
Fraud,’ in violation of 18 U.S.C. 1349,
one count of ‘Conspiracy to Pay and
Receive Illegal Health Care Kickbacks,’
in violation of 18 U.S.C. 371, fifteen
counts of ‘Health Care Fraud,’ in
violation of 18 U.S.C. 1347 and 2, and
one count of ‘Obstruction of a Federal
Audit,’ in violation of 18 U.S.C. 1516
and 2.’’ RFAA EX 3 (Judgment in a
Criminal Case at 1, United States v.
Barnes, No. 2:15–cr–61–SM–JCW (E.D.
La. September 28, 2018).
By letter dated March 29, 2019, HHS
OIG notified Registrant of his exclusion
from Medicare, Medicaid, and all
federal health care programs under 42
U.S.C. 1320a–7(a) for a minimum period
of twenty-five years based on
Registrant’s felony convictions in E.D.
La. RFAA, EX 4 (hereinafter, Exclusion
Letter), at 1. The Exclusion Letter stated
that the period of exclusion was greater
than the minimum of five years, because
the acts resulting in conviction ‘‘caused
a financial loss to a government agency
or program or to one or more entities of
$50,000 or more,’’ and specifically, the
court ordered Registrant ‘‘to pay
approximately $10,850,200 in
restitution.’’ Id. at 2. Further, the HHS
OIG reasoned that ‘‘the acts were
committed over a period of one year or
more,’’ and specifically, that ‘‘the acts
occurred from November 2008 to about
May 2014.’’ Id. Finally, the HHS OIG
considered whether the Registrant was
incarcerated and found that the ‘‘court
sentenced [Registrant] to 60 months of
incarceration.’’ Id. Per the Exclusion
Letter, the exclusion became effective
twenty days from the date of the letter,
or April 18, 2019. Id. at 1. The
Exclusion Letter notified Registrant of
his appeal rights. Id. at 2–4.
Accordingly, I find that the HHS OIG
excluded Registrant from Medicare,
Medicaid, and all federal health care
programs under 42 U.S.C. 1320a–7(a) for
twenty-five years, effective April 18,
2019, based on Registrant’s convictions
in the E.D. La.
Discussion
Under Section 824(a) of the
Controlled Substances Act (hereinafter,
CSA), a registration may be suspended
or revoked upon a finding of one or
more of five grounds. Each subsection of
Section 824(a) provides an independent
VerDate Sep<11>2014
16:47 Jan 31, 2020
Jkt 250001
ground to impose a sanction on a
registrant. Arnold E. Feldman, M.D., 82
FR 39614, 39617 (2017); see also Gilbert
L. Franklin, D.D.S., 57 FR 3441 (1992)
(‘‘[M]andatory exclusion from
participation in the Medicare program
constitutes an independent ground for
revocation pursuant to 21 U.S.C. [§ ]
824(a)(5).’’). The ground in 21 U.S.C.
824(a)(5) requires that the registrant
‘‘has been excluded (or directed to be
excluded) from participation in a
program pursuant to section 1320a–7(a)
of Title 42.’’ 42 U.S.C. 1320a–7(a)
provides a list of four predicate offenses
for which exclusion from Medicare,
Medicaid, and other federal health care
programs is mandatory and sets out
mandatory timeframes for such
exclusion. Id.
When a registrant facing a sanction
under 21 U.S.C. 824(a)(5) offers no
mitigating evidence for the
Administrator to consider, ‘‘it is
reasonable that the Administrator might
revoke or suspend.’’ Jeffrey Stein, M.D.,
84 FR 46968, 46971 (2019); see, e.g.,
Narciso A. Reyes, M.D., 83 FR 61678,
61681 (2018); Richard Hauser, M.D., 83
FR 26308, 26310 (2018). Further,
‘‘[t]here does not need to be a nexus to
controlled substances to make a
connection between the activity that
caused the mandatory exclusion and the
potential for abuse of a DEA
registration.’’ Jeffrey Stein, M.D., 84 FR
at 46972; Narciso Reyes, M.D., 83 FR at
61681; KKK Pharmacy, 64 FR 49507,
49510 (1999) (collecting cases); Melvin
N. Seglin, M.D., 63 Red. Reg. 70431,
70433 (1998); Stanley Dubin, D.D.S., 61
FR 60727, 60728 (1996).
Here, there is no dispute in the record
that Registrant is mandatorily excluded
pursuant to Section 1320a–7(a) of Title
42 and, therefore, that a ground for the
revocation or suspension of Registrant’s
registration exists. 21 U.S.C. 824(a)(5).
Indeed, Registrant was convicted of
multiple counts involving fraud,
kickbacks, and obstruction of a federal
audit. The HHS OIG estimated that
Registrant’s criminality spanned six
years and resulted in a financial loss of
approximately $10,850,200. RFAA, EX
4, at 2.
Where, as here, the Government has
met its prima facie burden of showing
that a ground for revocation exists, the
burden shifts to the Registrant to show
why he can be entrusted with a
registration. See Jeffrey Stein, M.D., 84
FR at 46972. Registrant, as already
discussed, failed to respond in any way
to the OSC. See RFAA, at 6. Therefore,
among other things, Registrant has not
accepted responsibility for his
criminality, shown any remorse for it, or
provided any assurance that he would
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
not repeat it. See Jeffrey Stein, M.D., 84
FR at 46972–74. Such silence weighs
against the Registrant’s continued
registration. Zvi H. Perper, M.D., 77 FR
64131, 64142 (2012) (citing Medicine
Shoppe-Jonesborough, 73 FR 264, 387
(2008); Samuel S. Jackson, 72 FR 23848,
23853 (2007)); see also Jones Total
Health Care Pharmacy, LLC v. Drug
Enf’t Admin., 881 F.3d 823, 831 (11th
Cir. 2018) (‘‘ ‘An agency rationally may
conclude that past performance is the
best predictor of future performance.’ ’’
(quoting Alra Laboratories, Inc. v. Drug
Enf’t Admin., 54 F.3d 450, 452 (7th Cir.
1995))).
Based on the record before me, I
conclude that Registrant’s founded
criminality involving dishonesty and
obstruction, resulting in his exclusion
from Medicare, Medicaid, and all
federal health care programs, makes him
ineligible for a DEA registration at this
time. Accordingly, I shall order the
sanctions the Government requested, as
contained in the Order below.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. BB1040269 issued to
Shelton W. Barnes, M.D. Further, I
hereby deny any pending application of
Shelton W. Barnes, M.D., to renew or
modify this registration, as well as any
pending application of Shelton W.
Barnes, M.D., for registration in
Louisiana. This Order is effective March
4, 2020.
Dated: January 3, 2020.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2020–01967 Filed 1–31–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–576]
Bulk Manufacturer of Controlled
Substances Application: Noramco Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 3, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
E:\FR\FM\03FEN1.SGM
03FEN1
Agencies
[Federal Register Volume 85, Number 22 (Monday, February 3, 2020)]
[Notices]
[Pages 5983-5984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01967]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Shelton W. Barnes, M.D.; Decision and Order
On June 28, 2019, the Assistant Administrator, Diversion Control
Division, Drug Enforcement Administration (hereinafter, DEA or
Government), issued an Order to Show Cause to Shelton W. Barnes, M.D.,
(hereinafter, Registrant), of New Orleans, Louisiana. Order to Show
Cause (hereinafter, OSC), at 1. The OSC proposed the revocation of
Registrant's Certificate of Registration No. BB1040269, because the
United States Department of Health and Human Services, Office of
Inspector General (hereinafter, HHS OIG) ``mandatorily excluded
[Registrant] from participation in Medicare, Medicaid, and all Federal
health care programs for a minimum period of twenty-five years pursuant
to 42 U.S.C. 1320a-7(a)''; and such exclusion ``warrants revocation of
[Registrant's] registration pursuant to 21 U.S.C. 824(a)(5).'' Id. at
2.
Specifically, the OSC alleged that, on September 25, 2018, Judgment
was entered against Registrant in the United States District Court for
the Eastern District of Louisiana (hereinafter, E.D. La.) ``based on
[Registrant's] conviction on one count of `Conspiracy to Commit Health
Care Fraud,' in violation of 18 U.S.C. 1349, one count of `Conspiracy
to Pay and Receive Illegal Health Care Kickbacks,' in violation of 18
U.S.C. 371, fifteen counts of `Health Care Fraud,' in violation of 18
U.S.C. 1347 and 2,\1\ and one count of `Obstruction of a Federal
Audit,' in violation of 18 U.S.C. 1516 and 2.'' \2\ Id. at 2 (citing
United States v. Barnes, No. 2:15-cr-0061-SM-JCW (E.D. La. 2018)). The
OSC further alleged that ``based on [such] conviction, HHS OIG, by
letter dated March 29, 2019, mandatorily excluded [Registrant] from
participation in Medicare, Medicaid, and all Federal health care
programs for a minimum period of twenty-five years pursuant to 42
U.S.C. 1320a-7(a), effective April 18, 2019.'' Id.
---------------------------------------------------------------------------
\1\ The Court's notation of 18 U.S.C. 2 appears in this format,
which was replicated in the OSC.
\2\ See n.1.
---------------------------------------------------------------------------
The Show Cause Order notified Registrant of the right to request a
hearing on the allegations or to submit a written statement, while
waiving the right to a hearing, the procedures for electing each
option, and the consequences for failing to elect either option. Id. at
2-3 (citing 21 CFR 1301.43). The OSC also notified Registrant of the
opportunity to submit a corrective action plan. Id. at 3-4 (citing 21
U.S.C. 824(c)(2)(C)).
Adequacy of Service
In a Declaration, dated October 24, 2019, a Diversion Investigator
(hereinafter, DI) assigned to the New Orleans Field Division stated
that she and another DI traveled to the Federal Prison Camp Pensacola,
110 Raby Ave., Pensacola, Florida 32509, where Registrant was
incarcerated, on July 10, 2019. Request for Final Agency Action
(hereinafter, RFAA), EX 6 (Declaration of Service). The DI stated that
they were taken to a room where correctional officers brought in
Registrant, who ``was wearing an inmate nametag with his name on it,''
and she further ``recognized him based on his driver's license photo.''
Id. The DI then ``handed the [OSC] to [Registrant] and explained it to
him, including his options to request a hearing or surrender his
registration.'' Id.
The Government submitted its RFAA, along with the evidentiary
record, for adjudication on December 4, 2019. In its RFAA, the
Government represented that ``at least thirty days have passed since
the . . . [OSC] was served on Registrant. Registrant has not requested
a hearing and has not otherwise corresponded or communicated with DEA
regarding the Order served on him, including the filing of any written
statement in lieu of a hearing.'' RFAA, at 2. The Government requested
that Registrant's Certificate of Registration be revoked and his
pending application for renewal be denied ``because Registrant lacks
state authority and because Registrant has been excluded from Medicare,
Medicaid and all Federal health care programs, either of which alone is
a sufficient basis to revoke Registrant's registration . . . .'' \3\
Id. at 7.
---------------------------------------------------------------------------
\3\ In the RFAA, the Government argued for revocation based on a
ground that does not appear in the OSC--that the Registrant
currently lacks authority to practice medicine in Louisiana, the
state in which he is registered with the DEA, and his registration
is thus also subject to revocation pursuant to 21 U.S.C. 824(a)(3).
Although state authority is a prerequisite to holding (or having) a
DEA registration, see 21 U.S.C. 823, I see no evidence in the record
that Registrant was notified of this additional charge. As such, he
has had no opportunity to determine whether to address the status of
his state authority. See Hatem M. Ataya, M.D., 81 FR 8221, 8245
(2016) (permitting the consideration of 21 U.S.C. 824(a)(3), because
the respondent had a ``meaningful opportunity to show that he
retains his state authority.''). In this case, I decline to allow
the Government to add the lack of state authority charge.
---------------------------------------------------------------------------
Based on the Government's representations and my review of the
record, I find that the Government served the OSC on Registrant on July
10, 2019. I also find that more than thirty days have now passed since
the date of service. Further, based on the Government's
representations, I find that neither Registrant, nor anyone purporting
to represent the Registrant, requested a hearing, submitted a written
statement while waiving Registrant's right to a hearing, or submitted a
corrective action plan. Accordingly, I find that Registrant has waived
the right to a hearing and the right to submit a written statement and
corrective action plan. 21 CFR Sec. 1301.43(d) and 21 U.S.C.
824(c)(2)(C). I, therefore, issue this Decision and Order based on the
record submitted by the Government, which constitutes the entire record
before me. 21 CFR 1301.43(e).
Findings of Fact
Registrant's DEA Registration
Registrant is the holder of DEA Certificate of Registration No.
BB1040269 at the registered address of 3600 Prytania, Suite 50, New
Orleans, LA 70115. RFAA, EX 1 (Certificate of Registration History), at
1. Pursuant to this registration, Registrant is authorized to dispense
controlled substances in schedules II through V as a practitioner. Id.
Registrant's registration was set to expire on July 31, 2018, but on
that date, Registrant submitted an online renewal application for 10555
Lake Forest Blvd., Ste. 5J, New Orleans, LA 70127-5208,
[[Page 5984]]
and his registration is currently ``in a renewal pending status.'' Id.
Registrant's Exclusion
The evidence in the record demonstrates that, on September 25,
2018, Judgment was entered against Registrant in E.D. La. ``based on
[Registrant's] conviction on one count of `Conspiracy to Commit Health
Care Fraud,' in violation of 18 U.S.C. 1349, one count of `Conspiracy
to Pay and Receive Illegal Health Care Kickbacks,' in violation of 18
U.S.C. 371, fifteen counts of `Health Care Fraud,' in violation of 18
U.S.C. 1347 and 2, and one count of `Obstruction of a Federal Audit,'
in violation of 18 U.S.C. 1516 and 2.'' RFAA EX 3 (Judgment in a
Criminal Case at 1, United States v. Barnes, No. 2:15-cr-61-SM-JCW
(E.D. La. September 28, 2018).
By letter dated March 29, 2019, HHS OIG notified Registrant of his
exclusion from Medicare, Medicaid, and all federal health care programs
under 42 U.S.C. 1320a-7(a) for a minimum period of twenty-five years
based on Registrant's felony convictions in E.D. La. RFAA, EX 4
(hereinafter, Exclusion Letter), at 1. The Exclusion Letter stated that
the period of exclusion was greater than the minimum of five years,
because the acts resulting in conviction ``caused a financial loss to a
government agency or program or to one or more entities of $50,000 or
more,'' and specifically, the court ordered Registrant ``to pay
approximately $10,850,200 in restitution.'' Id. at 2. Further, the HHS
OIG reasoned that ``the acts were committed over a period of one year
or more,'' and specifically, that ``the acts occurred from November
2008 to about May 2014.'' Id. Finally, the HHS OIG considered whether
the Registrant was incarcerated and found that the ``court sentenced
[Registrant] to 60 months of incarceration.'' Id. Per the Exclusion
Letter, the exclusion became effective twenty days from the date of the
letter, or April 18, 2019. Id. at 1. The Exclusion Letter notified
Registrant of his appeal rights. Id. at 2-4.
Accordingly, I find that the HHS OIG excluded Registrant from
Medicare, Medicaid, and all federal health care programs under 42
U.S.C. 1320a-7(a) for twenty-five years, effective April 18, 2019,
based on Registrant's convictions in the E.D. La.
Discussion
Under Section 824(a) of the Controlled Substances Act (hereinafter,
CSA), a registration may be suspended or revoked upon a finding of one
or more of five grounds. Each subsection of Section 824(a) provides an
independent ground to impose a sanction on a registrant. Arnold E.
Feldman, M.D., 82 FR 39614, 39617 (2017); see also Gilbert L. Franklin,
D.D.S., 57 FR 3441 (1992) (``[M]andatory exclusion from participation
in the Medicare program constitutes an independent ground for
revocation pursuant to 21 U.S.C. [Sec. ] 824(a)(5).''). The ground in
21 U.S.C. 824(a)(5) requires that the registrant ``has been excluded
(or directed to be excluded) from participation in a program pursuant
to section 1320a-7(a) of Title 42.'' 42 U.S.C. 1320a-7(a) provides a
list of four predicate offenses for which exclusion from Medicare,
Medicaid, and other federal health care programs is mandatory and sets
out mandatory timeframes for such exclusion. Id.
When a registrant facing a sanction under 21 U.S.C. 824(a)(5)
offers no mitigating evidence for the Administrator to consider, ``it
is reasonable that the Administrator might revoke or suspend.'' Jeffrey
Stein, M.D., 84 FR 46968, 46971 (2019); see, e.g., Narciso A. Reyes,
M.D., 83 FR 61678, 61681 (2018); Richard Hauser, M.D., 83 FR 26308,
26310 (2018). Further, ``[t]here does not need to be a nexus to
controlled substances to make a connection between the activity that
caused the mandatory exclusion and the potential for abuse of a DEA
registration.'' Jeffrey Stein, M.D., 84 FR at 46972; Narciso Reyes,
M.D., 83 FR at 61681; KKK Pharmacy, 64 FR 49507, 49510 (1999)
(collecting cases); Melvin N. Seglin, M.D., 63 Red. Reg. 70431, 70433
(1998); Stanley Dubin, D.D.S., 61 FR 60727, 60728 (1996).
Here, there is no dispute in the record that Registrant is
mandatorily excluded pursuant to Section 1320a-7(a) of Title 42 and,
therefore, that a ground for the revocation or suspension of
Registrant's registration exists. 21 U.S.C. 824(a)(5). Indeed,
Registrant was convicted of multiple counts involving fraud, kickbacks,
and obstruction of a federal audit. The HHS OIG estimated that
Registrant's criminality spanned six years and resulted in a financial
loss of approximately $10,850,200. RFAA, EX 4, at 2.
Where, as here, the Government has met its prima facie burden of
showing that a ground for revocation exists, the burden shifts to the
Registrant to show why he can be entrusted with a registration. See
Jeffrey Stein, M.D., 84 FR at 46972. Registrant, as already discussed,
failed to respond in any way to the OSC. See RFAA, at 6. Therefore,
among other things, Registrant has not accepted responsibility for his
criminality, shown any remorse for it, or provided any assurance that
he would not repeat it. See Jeffrey Stein, M.D., 84 FR at 46972-74.
Such silence weighs against the Registrant's continued registration.
Zvi H. Perper, M.D., 77 FR 64131, 64142 (2012) (citing Medicine Shoppe-
Jonesborough, 73 FR 264, 387 (2008); Samuel S. Jackson, 72 FR 23848,
23853 (2007)); see also Jones Total Health Care Pharmacy, LLC v. Drug
Enf't Admin., 881 F.3d 823, 831 (11th Cir. 2018) (`` `An agency
rationally may conclude that past performance is the best predictor of
future performance.' '' (quoting Alra Laboratories, Inc. v. Drug Enf't
Admin., 54 F.3d 450, 452 (7th Cir. 1995))).
Based on the record before me, I conclude that Registrant's founded
criminality involving dishonesty and obstruction, resulting in his
exclusion from Medicare, Medicaid, and all federal health care
programs, makes him ineligible for a DEA registration at this time.
Accordingly, I shall order the sanctions the Government requested, as
contained in the Order below.
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
BB1040269 issued to Shelton W. Barnes, M.D. Further, I hereby deny any
pending application of Shelton W. Barnes, M.D., to renew or modify this
registration, as well as any pending application of Shelton W. Barnes,
M.D., for registration in Louisiana. This Order is effective March 4,
2020.
Dated: January 3, 2020.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2020-01967 Filed 1-31-20; 8:45 am]
BILLING CODE 4410-09-P